GSK3β is a new therapeutic target for myotonic dystrophy type 1

References

• Harper PS. Myotonic Dystrophy. London: WB Saunders, 2001.
   Google Scholar
• Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudson T, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992; 68:799 - 808; http://dx.doi.org/10.1016/0092-8674(92)90154-5; PMID: 1310900
   PubMed Web of Science ®Google Scholar
• Fu YH, Pizzuti A, Fenwick RG Jr., King J, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, de Jong P, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992; 255:1256 - 8; http://dx.doi.org/10.1126/science.1546326; PMID: 1546326
   PubMed Web of Science ®Google Scholar
• Timchenko LT. Myotonic dystrophy: the role of RNA CUG triplet repeats. Am J Hum Genet 1999; 64:360 - 4; http://dx.doi.org/10.1086/302268; PMID: 9973273
   PubMed Web of Science ®Google Scholar
• Mankodi A, Logigian E, Callahan L, McClain C, White R, Henderson D, Krym M, Thornton CA. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 2000; 289:1769 - 73; http://dx.doi.org/10.1126/science.289.5485.1769; PMID: 10976074
   PubMed Web of Science ®Google Scholar
• Seznec H, Agbulut O, Sergeant N, Savouret C, Ghestem A, Tabti N, Willer JC, Ourth L, Duros C, Brisson E, et al. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum Mol Genet 2001; 10:2717 - 26; http://dx.doi.org/10.1093/hmg/10.23.2717; PMID: 11726559
   PubMed Web of Science ®Google Scholar
• Ranum LP, Cooper TA. RNA-mediated neuromuscular disorders. Annu Rev Neurosci 2006; 29:259 - 77; http://dx.doi.org/10.1146/annurev.neuro.29.051605.113014; PMID: 16776586
   PubMed Web of Science ®Google Scholar
• Schoser B, Timchenko L. Myotonic dystrophies 1 and 2: complex diseases with complex mechanisms. Curr Genomics 2010; 11:77 - 90; http://dx.doi.org/10.2174/138920210790886844; PMID: 20885816
   PubMed Web of Science ®Google Scholar
• Timchenko LT, Timchenko NA, Caskey CT, Roberts R. Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy. Hum Mol Genet 1996; 5:115 - 21; http://dx.doi.org/10.1093/hmg/5.1.115; PMID: 8789448
   PubMed Web of Science ®Google Scholar
• Timchenko LT, Miller JW, Timchenko NA, DeVore DR, Datar KV, Lin L, Roberts R, Caskey CT, Swanson MS. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res 1996; 24:4407 - 14; http://dx.doi.org/10.1093/nar/24.22.4407; PMID: 8948631
   PubMed Web of Science ®Google Scholar
• Miller JW, Urbinati CR, Teng-Umnuay P, Stenberg MG, Byrne BJ, Thornton CA, Swanson MS. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J 2000; 19:4439 - 48; http://dx.doi.org/10.1093/emboj/19.17.4439; PMID: 10970838
   PubMed Web of Science ®Google Scholar
• Taneja KL, McCurrach M, Schalling M, Housman D, Singer RH. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol 1995; 128:995 - 1002; http://dx.doi.org/10.1083/jcb.128.6.995; PMID: 7896884
   PubMed Web of Science ®Google Scholar
• Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thornton CA, Esson D, Timmers AM, Hauswirth WW, Swanson MS. A muscleblind knockout model for myotonic dystrophy. Science 2003; 302:1978 - 80; http://dx.doi.org/10.1126/science.1088583; PMID: 14671308
   PubMed Web of Science ®Google Scholar
• Timchenko NA, Cai Z-J, Welm AL, Reddy S, Ashizawa T, Timchenko LT. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J Biol Chem 2001; 276:7820 - 6; http://dx.doi.org/10.1074/jbc.M005960200; PMID: 11124939
   PubMed Web of Science ®Google Scholar
• Savkur RS, Philips AV, Cooper TA. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 2001; 29:40 - 7; http://dx.doi.org/10.1038/ng704; PMID: 11528389
   PubMed Web of Science ®Google Scholar
• Kuyumcu-Martinez NM, Wang GS, Cooper TA. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol Cell 2007; 28:68 - 78; http://dx.doi.org/10.1016/j.molcel.2007.07.027; PMID: 17936705
   PubMed Web of Science ®Google Scholar
• Huichalaf C, Sakai K, Jin B, Jones K, Wang G-L, Schoser B, Schneider-Gold C, Sarkar P, Pereira-Smith OM, Timchenko N, et al. Expansion of CUG RNA repeats causes stress and inhibition of translation in myotonic dystrophy 1 (DM1) cells. FASEB J 2010; 24:3706 - 19; http://dx.doi.org/10.1096/fj.09-151159; PMID: 20479119
   PubMed Web of Science ®Google Scholar
• Timchenko NA, Wang G-L, Timchenko LT. RNA CUG-binding protein 1 increases translation of 20-kDa isoform of CCAAT/enhancer-binding protein beta by interacting with the alpha and beta subunits of eukaryotic initiation translation factor 2. J Biol Chem 2005; 280:20549 - 57; http://dx.doi.org/10.1074/jbc.M409563200; PMID: 15788409
   PubMed Web of Science ®Google Scholar
• Timchenko LT, Salisbury E, Wang G-L, Nguyen H, Albrecht JH, Hershey JWB, Timchenko NA. Age-specific CUGBP1-eIF2 complex increases translation of CCAAT/enhancer-binding protein beta in old liver. J Biol Chem 2006; 281:32806 - 19; http://dx.doi.org/10.1074/jbc.M605701200; PMID: 16931514
   PubMed Web of Science ®Google Scholar
• Anderson P, Kedersha N. RNA granules. J Cell Biol 2006; 172:803 - 8; http://dx.doi.org/10.1083/jcb.200512082; PMID: 16520386
   PubMed Web of Science ®Google Scholar
• Paillard L, Omilli F, Legagneux V, Bassez T, Maniey D, Osborne HB. EDEN and EDEN-BP, a cis element and an associated factor that mediate sequence-specific mRNA deadenylation in Xenopus embryos. EMBO J 1998; 17:278 - 87; http://dx.doi.org/10.1093/emboj/17.1.278; PMID: 9427761
   PubMed Web of Science ®Google Scholar
• Philips AV, Timchenko LT, Cooper TA. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 1998; 280:737 - 41; http://dx.doi.org/10.1126/science.280.5364.737; PMID: 9563950
   PubMed Web of Science ®Google Scholar
• Charlet-B N, Savkur RS, Singh G, Philips AV, Grice EA, Cooper TA, Charlet-BN. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 2002; 10:45 - 53; http://dx.doi.org/10.1016/S1097-2765(02)00572-5; PMID: 12150906
   PubMed Web of Science ®Google Scholar
• Rattenbacher B, Beisang D, Wiesner DL, Jeschke JC, von Hohenberg M, St Louis-Vlasova IA, Bohjanen PR. Analysis of CUGBP1 targets identifies GU-repeat sequences that mediate rapid mRNA decay. Mol Cell Biol 2010; 30:3970 - 80; http://dx.doi.org/10.1128/MCB.00624-10; PMID: 20547756
   PubMed Web of Science ®Google Scholar
• Jones K, Wei C, Iakova P, Bugiardini E, Schneider-Gold C, Meola G, Woodgett J, Killian J, Timchenko NA, Timchenko LT. GSK3β mediates muscle pathology in myotonic dystrophy. J Clin Invest 2012; 122:4461 - 72; http://dx.doi.org/10.1172/JCI64081; PMID: 23160194
   PubMed Web of Science ®Google Scholar
• Naderi S, Gutzkow KB, Låhne HU, Lefdal S, Ryves WJ, Harwood AJ, Blomhoff HK. cAMP-induced degradation of cyclin D3 through association with GSK-3beta. J Cell Sci 2004; 117:3769 - 83; http://dx.doi.org/10.1242/jcs.01210; PMID: 15252116
   PubMed Web of Science ®Google Scholar
• Wheeler TM, Sobczak K, Lueck JD, Osborne RJ, Lin X, Dirksen RT, Thornton CA. Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science 2009; 325:336 - 9; http://dx.doi.org/10.1126/science.1173110; PMID: 19608921
   PubMed Web of Science ®Google Scholar
• Mulders SA, van den Broek WJ, Wheeler TM, Croes HJ, van Kuik-Romeijn P, de Kimpe SJ, Furling D, Platenburg GJ, Gourdon G, Thornton CA, et al. Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. Proc Natl Acad Sci U S A 2009; 106:13915 - 20; http://dx.doi.org/10.1073/pnas.0905780106; PMID: 19667189
   PubMed Web of Science ®Google Scholar
• Wheeler TM, Leger AJ, Pandey SK, MacLeod AR, Nakamori M, Cheng SH, Wentworth BM, Bennett CF, Thornton CA. Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 2012; 488:111 - 5; http://dx.doi.org/10.1038/nature11362; PMID: 22859208
   PubMed Web of Science ®Google Scholar
• Doble BW, Woodgett JR. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 2003; 116:1175 - 86; http://dx.doi.org/10.1242/jcs.00384; PMID: 12615961
   PubMed Web of Science ®Google Scholar